BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17173941)

  • 1. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
    Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
    Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
    Skildum A; Faivre E; Lange CA
    Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
    Daniel AR; Faivre EJ; Lange CA
    Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.
    Qiu M; Olsen A; Faivre E; Horwitz KB; Lange CA
    Mol Endocrinol; 2003 Apr; 17(4):628-42. PubMed ID: 12554776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
    Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
    J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
    Shen T; Horwitz KB; Lange CA
    Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
    Faivre EJ; Daniel AR; Hillard CJ; Lange CA
    Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
    Daniel AR; Lange CA
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14287-92. PubMed ID: 19706513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.
    Carvajal A; Espinoza N; Kato S; Pinto M; Sadarangani A; Monso C; Aranda E; Villalon M; Richer JK; Horwitz KB; Brosens JJ; Owen GI
    Breast Cancer Res Treat; 2005 Nov; 94(2):171-83. PubMed ID: 16175315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.
    Pierson-Mullany LK; Lange CA
    Mol Cell Biol; 2004 Dec; 24(24):10542-57. PubMed ID: 15572662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
    Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
    Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
    Diep CH; Knutson TP; Lange CA
    Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
    Hagan CR; Regan TM; Dressing GE; Lange CA
    Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways.
    Lange CA; Richer JK; Shen T; Horwitz KB
    J Biol Chem; 1998 Nov; 273(47):31308-16. PubMed ID: 9813039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
    Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
    Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
    Kawprasertsri S; Pietras RJ; Marquez-Garban DC; Boonyaratanakornkit V
    Cancer Lett; 2016 May; 374(2):279-91. PubMed ID: 26892043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.